FDA Inspection
Bio-Medical Pharmaceutical Manufacturing CorporationBio-Medical Pharmaceutical Manufacturing Corporation – FDA Inspection, Jan 23, 2020
Record Details
This FDA Inspection record concerns Bio-Medical Pharmaceutical Manufacturing Corporation, with an inspection on January 23, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 23, 2020
- Product Type
- Drugs
View Company Profile
ID · f0fb6179-5330-47b5-95ce-7c9e11cab514
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115699
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.68(a)Written calibration / inspection records not kept
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bio-Medical Pharmaceutical Manufacturing Corporation
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | OAI | Dallas District Office | Drug Quality Assurance |
| January 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 9, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bio-Medical Pharmaceutical Manufacturing Corporation
- FDA Inspection 1279930 - 2025-08-29
- FDA Inspection 960788 - 2016-01-14
- FDA Inspection 671855 - 2010-07-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.